Article Text

Download PDFPDF
CASE REPORT
Glucocorticoids did not reverse type 1 diabetes mellitus secondary to pembrolizumab in a patient with metastatic melanoma
  1. Jasna Aleksova1,
  2. Peter K H Lau2,
  3. Georgia Soldatos2,3,
  4. Grant McArthur4,5
  1. 1Monash Health, Clayton, Victoria, Australia
  2. 2Peter MacCallum Cancer Institute, Cancer Medicine, East Melbourne, Victoria, Australia
  3. 3Monash Centre for Health Research and Implementation, Melbourne, Victoria, Australia
  4. 4Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
  5. 5Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia
  1. Correspondence to Dr Jasna Aleksova, jasnaaleksova{at}hotmail.com

Footnotes

  • Jasna Aleksova and Pete K H Lau are joint first authors.

  • Contributors JA is responsible for involvement in case, manuscript preparation and writing. PL is responsible for involvement in case, manuscript preparation and writing. JA and PL are equal first authors. GS is responsible for assistance in case management and manuscript editing. GM is responsible for assistance in case management and manuscript editing.

  • Competing interests PL has received honoraria and travel funding from Bristol Myers Squibb.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Jasna Aleksova and Pete K H Lau are joint first authors.

  • Contributors JA is responsible for involvement in case, manuscript preparation and writing. PL is responsible for involvement in case, manuscript preparation and writing. JA and PL are equal first authors. GS is responsible for assistance in case management and manuscript editing. GM is responsible for assistance in case management and manuscript editing.

  • Competing interests PL has received honoraria and travel funding from Bristol Myers Squibb.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.